Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+13.64%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$59.3B
AUM Growth
+$5.38B
(+10%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
971
New
135
Increased
326
Reduced
323
Closed
128
Top Buys
| 1 |
Capital One
COF
|
+$120M |
| 2 |
CSX Corp
CSX
|
+$120M |
| 3 |
Amazon
AMZN
|
+$120M |
| 4 |
Johnson Controls International
JCI
|
+$114M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$108M |
Top Sells
| 1 |
3M
MMM
|
+$169M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$163M |
| 3 |
WESCO International
WCC
|
+$144M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$139M |
| 5 |
Royal Caribbean
RCL
|
+$130M |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Industrials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Core Scientific
CORZ
$4.88B
| $32.4M | 0.05% |
1,900,000
+900,000
| +90% | +$15.4M |
|
327
Gates Industrial
GTES
$6.52B
| $32.3M | 0.05% |
+1,400,585
| New | +$32.3M |
|
328
Zions Bancorporation
ZION
$8.56B
| $32M | 0.05% |
+616,248
| New | +$32M |
|
329
TE Connectivity
TEL
$62.2B
| $31.9M | 0.05% |
189,043
+48,345
| +34% | +$8.15M |
|
330
Phillips Edison & Co
PECO
$4.47B
| $31.9M | 0.05% |
910,000
-5,000
| -0.5% | -$175K |
|
331
News Corp Class A
NWSA
$16.2B
| $31.8M | 0.05% |
1,070,099
-224,500
| -17% | -$6.67M |
|
332
Kenvue
KVUE
$35.4B
| $31.8M | 0.05% |
1,518,958
-130,800
| -8% | -$2.74M |
|
333
Idexx Laboratories
IDXX
$51B
| $31.8M | 0.05% |
+59,201
| New | +$31.8M |
|
334
Fortive
FTV
$16.2B
| $31.7M | 0.05% |
607,522
+395,629
| +187% | +$20.6M |
|
335
Fulcrum Therapeutics
FULC
$378M
| $31.6M | 0.05% |
4,589,000
+1,589,000
| +53% | +$10.9M |
|
336
Truist Financial
TFC
$58.2B
| $31.6M | 0.05% |
734,364
+23,400
| +3% | +$1.01M |
|
337
Valero Energy
VLO
$49.2B
| $31.2M | 0.05% |
231,900
-7,000
| -3% | -$941K |
|
338
Biogen
BIIB
$20.9B
| $31.1M | 0.05% |
247,937
+177,170
| +250% | +$22.3M |
|
339
CoStar Group
CSGP
$36.6B
| $31.1M | 0.05% |
386,400
+1,800
| +0.5% | +$145K |
|
340
Delta Air Lines
DAL
$40.1B
| $30.9M | 0.05% |
628,011
-17,600
| -3% | -$866K |
|
341
Ingersoll Rand
IR
$31.9B
| $30.7M | 0.05% |
369,492
-55,095
| -13% | -$4.58M |
|
342
Centuri Holdings
CTRI
$2.02B
| $30.7M | 0.05% |
+1,369,228
| New | +$30.7M |
|
343
Align Technology
ALGN
$9.64B
| $30.6M | 0.05% |
161,811
+34,423
| +27% | +$6.52M |
|
344
Hilton Worldwide
HLT
$64.2B
| $30.6M | 0.05% |
114,900
+28,900
| +34% | +$7.7M |
|
345
Rio Tinto
RIO
$101B
| $30.6M | 0.05% |
524,602
+444,602
| +556% | +$25.9M |
|
346
Aura Biosciences
AURA
$400M
| $30.6M | 0.05% |
4,881,125
| – | – |
|
347
Kyndryl
KD
$7.49B
| $30.4M | 0.05% |
725,000
-540,000
| -43% | -$22.7M |
|
348
Dyne Therapeutics
DYN
$1.89B
| $30.4M | 0.05% |
+3,191,000
| New | +$30.4M |
|
349
Canadian Pacific Kansas City
CP
$68.4B
| $30.4M | 0.05% |
383,028
-461,787
| -55% | -$36.6M |
|
350
Tango Therapeutics
TNGX
$708M
| $30.2M | 0.05% |
+5,905,349
| New | +$30.2M |
|